Abstract
Ready-to-eat food (RTE) are foods that are intended by the producers for direct human consumption without the need for further preparation. The primary source of human Listeriosis is mainly through ingestion of contaminated RTE food products. Thus, implementing control strategies for Listeriosis infectious disease is vital for its management and eradication. In the present study, a deterministic model of Listeriosis disease transmission dynamics with control measures was analyzed. We assumed that humans are infected with Listeriosis either through ingestion of contaminated food products or directly with Listeria Monocytogenes in their environment. Equilibrium points of the model in the absence of control measures were determined, and their local asymptotic stability established. We formulate an optimal control problem and analytically give sufficient conditions for the optimality and the transversality conditions for the model with controls. Numerical simulations of the optimal control strategies were performed to illustrate the results. The numerical findings suggest that constant implementation of the joint optimal control measures throughout the modelling time will be more efficacious in controlling or reducing the Listeriosis disease. The results of this study can be used as baseline measures in controlling Listeriosis disease from ready-to-eat food products.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
4838721
Funding Statement
No funding recieved
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
4836874
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
None
